Algernon Pharmaceuticals Inc (AGNPF)

[GVX808]

I hear ya. The waiting game is no fun, especially on something as uncertain as FDA trials/approval. Definitely not for everyone, but it seems the risk/reward on $AGNPF makes pretty good sense.

Patience grasshopper... and just hope it pays off in the end.

I’m pretty sure we all thought U.S. FDA 2B/3 trial approval would at least get an uptrend started in the share price. It’s definitely no fun to see it dwindle on a daily basis.